KIMBERLY HIZER: Open Payments
NPI 1528614047 · BROWNSBURG, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 29 payments from 9 companies in 2025. Trend: 2023 $5 · 2024 $269 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $212 |
| Biogen, Inc. | 4 | $147 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| Alkermes, Inc. | 4 | $69 |
| Supernus Pharmaceuticals, Inc. | 4 | $62 |
| Corium, LLC | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Lundbeck LLC | 1 | $18 |
| Orexo US, Inc. | 1 | $17 |
Products named: SPRAVATO, ZURZUVAE, Qelbree, REXULTI, ARISTADA, Azstarys, ABILIFY ASIMTUFII, CAPLYTA.
Industry payments across IN — which companies pay providers there.
